BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33655961)

  • 1. MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
    Chen L; Ke X
    Medicine (Baltimore); 2021 Mar; 100(9):e24953. PubMed ID: 33655961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
    Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
    Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on Integrated Gene Expression Profile Analysis.
    Luu Truong Thanh H; Hoang TM; Hoang Van H
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):885-892. PubMed ID: 38546071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete ablation of colon cancer cells may induce activation of dormant cells: Evidence from bioinformatics analysis.
    Lin W; Liu J; Lv W; Liu C; Sun Y; Zuo T
    J Cancer Res Ther; 2020; 16(7):1596-1602. PubMed ID: 33565505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma.
    Xu S; Liu D; Cui M; Zhang Y; Zhang Y; Guo S; Zhang H
    Biomed Res Int; 2022; 2022():1893351. PubMed ID: 35774271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
    Gao P; He M; Zhang C; Geng C
    Gene; 2018 May; 654():95-102. PubMed ID: 29408621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of key biomarkers and pathways in KSHV infected endothelial cells.
    Gong HB; Wu XJ; Pu XM; Kang XJ
    Medicine (Baltimore); 2019 Jul; 98(27):e16277. PubMed ID: 31277155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.